B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
BPS-78363	2 vials		-	-	3 - 15 business days*		13,502.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from NFAT... more

Close menu

Product information "B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line"

B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from NFAT Luciferase Reporter Jurkat cells. Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity.

Keywords:	CDABP0092,
Supplier:	BPS Bioscience
Supplier-Nr:	78363

Properties

Application:	Study the consequences of B2M knock down or use as control in immune-oncology product development
Species reactivity:	human

Database Information

KEGG ID :	K08055 \| Matching products
UniProt ID :	P61769 \| Matching products
Gene ID	GeneID 567 \| Matching products

Handling & Safety

Storage:	Liquid nitrogen
Shipping:	-80°C (International: °C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line"

Write a review